Acceptance rate 46%
Time to first decision 20 days*
Time to decision with review 50 days*

*approximate number of days

ACTA Pharmaceutica Sciencia 2008 , Vol 50 , Num 2
Scintigraphic Assessment of the In situ Gelling Formulation of Gatifloxacin for Monitoring Ocular Residence: Enhancement of Ocular Residence Time
M. Abul Kalam Y. Sultana A. Ali M. Aqil M. Sharma A. K. Mishra K. Chuttani

Istanbul Medipol University